Taking Action on DIR Fees

September 15, 2016 | Jeremy Johnson

This week, four senators (Shelley Moore Capito, R-W.Va., Jon Tester, D-Mont., John Boozman, R-Ark., and Tom Cotton, R-Ark.) introduced bipartisan legislation to prohibit retroactive DIR fees in the “Improving Transparency and Accuracy in Medicare Part D Spending Act.”

NCPA—on behalf of the independent pharmacies it represents—has been a strong advocate for the move: 

“In banning retroactive DIR fees, S. 3308 / H.R. 5951 would improve transparency in Medicare Part D as many members of Congress, Medicare officials and NCPA have urged. The bill would also lower beneficiary cost-sharing at the pharmacy counter without increasing Medicare Part D costs.”

Continue reading →

Opportunities for Independent Pharmacies

April 28, 2016 | Pamela Youngberg Dickson

Over the past three decades, competition in pharmacy has increased exponentially. It started in the 80s, when the national chains gobbled up real estate; it continues today with many of those chains purchasing their way into limited networks through consolidation and the acquisition or creation of their own PBMs.

To help our own stores (the Sterling chain of regional pharmacies in southern Minnesota and Iowa) combat the downward pressure on margins and generally more competitive pharmacy market, we’ve been using a multi-pronged approach.

Continue reading →